Journal
ORAL DISEASES
Volume 18, Issue 3, Pages 236-243Publisher
WILEY
DOI: 10.1111/j.1601-0825.2011.01867.x
Keywords
interleukin-6; oral diseases; periodontitis; lichen planus; oral cancer; Sjogren's syndrome
Categories
Funding
- Department of Health's NIHR Biomedical Research Centres
- UK Clinical Research Collaboration
Ask authors/readers for more resources
Interleukin-6 (IL-6) is a pleomorphic cytokine involved in a number of physiologic and pathologic processes including response to trauma and infection and development and progression of inflammation and malignancy. IL-6 is emerging as an important mediator and novel therapeutic target for chronic inflammatory diseases and cancer. The present study reviews the available evidence regarding the association between IL-6 and a range of oral diseases including infections (periodontal disease and endodontic infections), immunologically mediated disorders (oral lichen planus and Sjogren's syndrome) and malignancy (oral cancer and precancer). The role of common genetic variants of IL-6 in determining individual susceptibility to certain oral diseases, as well as novel therapeutic strategies based on IL-6 inhibition are also discussed. Oral Diseases (2012) 18, 236-243
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available